These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


381 related items for PubMed ID: 21597461

  • 1. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
    Nakamura T, Lipton SA.
    Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA, Gu Z, Nakamura T.
    Int Rev Neurobiol; 2007 Sep; 82():1-27. PubMed ID: 17678953
    [Abstract] [Full Text] [Related]

  • 3. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Nakamura T, Lipton SA.
    Antioxid Redox Signal; 2011 Apr 15; 14(8):1479-92. PubMed ID: 20812868
    [Abstract] [Full Text] [Related]

  • 4. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Gu Z, Nakamura T, Lipton SA.
    Mol Neurobiol; 2010 Jun 15; 41(2-3):55-72. PubMed ID: 20333559
    [Abstract] [Full Text] [Related]

  • 5. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
    Nakamura T, Lipton SA.
    Apoptosis; 2010 Nov 15; 15(11):1354-63. PubMed ID: 20177970
    [Abstract] [Full Text] [Related]

  • 6. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA.
    Nature; 2006 May 25; 441(7092):513-7. PubMed ID: 16724068
    [Abstract] [Full Text] [Related]

  • 7. Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
    Nakamura T, Lipton SA.
    Cell Calcium; 2010 Feb 25; 47(2):190-7. PubMed ID: 20060165
    [Abstract] [Full Text] [Related]

  • 8. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
    Nakamura T, Prikhodko OA, Pirie E, Nagar S, Akhtar MW, Oh CK, McKercher SR, Ambasudhan R, Okamoto S, Lipton SA.
    Neurobiol Dis; 2015 Dec 25; 84():99-108. PubMed ID: 25796565
    [Abstract] [Full Text] [Related]

  • 9. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
    Nakamura T, Lipton SA.
    Antioxid Redox Signal; 2008 Jan 25; 10(1):87-101. PubMed ID: 17961071
    [Abstract] [Full Text] [Related]

  • 10. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA.
    Antioxid Redox Signal; 2013 Oct 10; 19(11):1173-84. PubMed ID: 23641925
    [Abstract] [Full Text] [Related]

  • 11. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T, Lipton SA.
    Cell Death Differ; 2007 Jul 10; 14(7):1305-14. PubMed ID: 17431424
    [Abstract] [Full Text] [Related]

  • 12. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.
    Nakamura T, Cho DH, Lipton SA.
    Exp Neurol; 2012 Nov 10; 238(1):12-21. PubMed ID: 22771760
    [Abstract] [Full Text] [Related]

  • 13. PDI-mediated S-nitrosylation of DRP1 facilitates DRP1-S616 phosphorylation and mitochondrial fission in CA1 neurons.
    Lee DS, Kim JE.
    Cell Death Dis; 2018 Aug 29; 9(9):869. PubMed ID: 30158524
    [Abstract] [Full Text] [Related]

  • 14. S-Nitrosylation in Alzheimer's disease.
    Zhao QF, Yu JT, Tan L.
    Mol Neurobiol; 2015 Feb 29; 51(1):268-80. PubMed ID: 24664522
    [Abstract] [Full Text] [Related]

  • 15. Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer's disease.
    Honjo Y, Horibe T, Torisawa A, Ito H, Nakanishi A, Mori H, Komiya T, Takahashi R, Kawakami K.
    J Alzheimers Dis; 2014 Feb 29; 38(3):601-9. PubMed ID: 24037032
    [Abstract] [Full Text] [Related]

  • 16. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.
    Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA.
    Science; 2009 Apr 03; 324(5923):102-5. PubMed ID: 19342591
    [Abstract] [Full Text] [Related]

  • 17. S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.
    Nakamura T, Cieplak P, Cho DH, Godzik A, Lipton SA.
    Mitochondrion; 2010 Aug 03; 10(5):573-8. PubMed ID: 20447471
    [Abstract] [Full Text] [Related]

  • 18. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
    Bossy B, Petrilli A, Klinglmayr E, Chen J, Lütz-Meindl U, Knott AB, Masliah E, Schwarzenbacher R, Bossy-Wetzel E.
    J Alzheimers Dis; 2010 Aug 03; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
    [Abstract] [Full Text] [Related]

  • 19. Intracellular Accumulation of α-Synuclein Aggregates Promotes S-Nitrosylation of MAP1A Leading to Decreased NMDAR-Evoked Calcium Influx and Loss of Mature Synaptic Spines.
    Hallam RD, Buchner-Duby B, Stykel MG, Coackley CL, Ryan SD.
    J Neurosci; 2022 Dec 14; 42(50):9473-9487. PubMed ID: 36414406
    [Abstract] [Full Text] [Related]

  • 20. PDI-Mediated Reduction of Disulfide Bond on PSD95 Increases Spontaneous Seizure Activity by Regulating NR2A-PSD95 Interaction in Epileptic Rats Independent of S-Nitrosylation.
    Lee DS, Kim JE.
    Int J Mol Sci; 2020 Mar 18; 21(6):. PubMed ID: 32197489
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.